DRUG-BINDING MACROMOLECULAR LIPIDS FROM L1210 LEUKEMIA TUMORSTAYLOR RF; TEAGUE LA; YESAIR DW et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 11; PART. 1; PP. 4316-4323; BIBL. 38 REF.Article

CHARACTERIZATION OF THE URINARY METABOLITES OF 5-AZACYTIDINE IN MICEKELLY CJ; COLES E; GAUDIO L et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 4; PP. 609-615; BIBL. 34 REF.Article

THE EFFECT OF COFFEE CONSUMPTION ON PLASMA LIPIDS, LIPOPROTEINS, AND THE DEVELOPMENT OF AORTIC ATHEROSCLEROSIS IN RHESUS MONKEYS FED AN ATHEROGENIC DIETCALLAHAN MM; ROHOVSKY MW; ROBERTSON RS et al.1979; AMER. J. CLIN. NUTRIT.; USA; DA. 1979; VOL. 32; NO 4; PP. 834-845; BIBL. 68 REF.Article

COMPARATIVE PHARMACOKINETICS OF DAUNOMYCIN AND ADRIAMYCIN IN SEVERAL ANIMAL SPECIESYESAIR DW; SCHWARTZBACH E; SHUCK D et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 6; PP. 1177-1183; BIBL. 21 REF.Serial Issue

METABOLISM OF DAUNOMYCIN (NSC-82151) IN VITRO AND THE CHEMOTHERAPEUTIC ACTIVITY OF ISOLATED METABOLITES IN VIVOASBELL MA; SCHWARTZBACH E; WODINSKY I et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 315-320; BIBL. 18REF.Serial Issue

COMPARISON OF CAFFEINE METABOLISM IN THREE NONSMOKING POPULATIONS AFTER ORAL ADMINISTRATION OF RADIOLABELED CAFFEINECALLAHAN MM; ROBERTSON RS; BRANFMAN AR et al.1983; DRUG METABOLISM AND DISPOSITION; ISSN 0090-9556; USA; DA. 1983; VOL. 11; NO 3; PP. 211-217; BIBL. 27 REF.Article

BINDING OF THE CAIN QUINOLINIUM, NSC 113089, TO RAT TISSUE LIPID EXTRACTSYESAIR DW; CALLAHAN M; MCCOMISH MF et al.1979; CANCER BIOCHEM. BIOPHYS.; GBR; DA. 1979; VOL. 3; NO 4; PP. 163-168; BIBL. 10 REF.Article

IMPORTANCE OF SCHEDULE IN ADRIAMYCIN/CYCLOPHOSPHAMIDE COMBINATION CHEMOTHERAPY.YESAIR DW; MCNITT S; TOBIAS J et al.1978; EUROP. J. CANCER; G.B.; DA. 1978; VOL. 14; NO 2; PP. 141-146; BIBL. 15 REF.Article

PHARMACOKINETIC CONSIDERATIONS IN EVALUATING THE EFFECTS OF TETRAHYDROURIDINE ON 5-AZACYTIDINE CHEMOTHERAPY IN L1210 LEUKEMIC MICE.KELLY CJ; GAUDIO L; YESAIR DW et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 7; PP. 1025-1032; BIBL. 35 REF.Article

COMPARATIVE PHYSIOLOGICAL DISPOSITION OF N-(PHOSPHONACETYL)-L-ASPARTATE IN SEVERAL ANIMAL SPECIES AFTER INTRAVENOUS AND ORAL ADMINISTRATIONCHADWICK M; SILVEIRA DM; MACGREGOR JA et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 2; PP. 627-632; BIBL. 31 REF.Article

HUMAN METABOLISM OF (1-METHYL-¹⁴C)- AND (2-¹⁴C) CAFFEINE AFTER ORAL ADMINISTRATIONCALLAHAN MM; ROBERTSON RS; ARNAUD MJ et al.1982; DRUG. METAB. DISPOS.; ISSN 0090-9556; USA; DA. 1982; VOL. 10; NO 4; PP. 417-423; BIBL. 30 REF.Article

CHARACTERIZATION OF DIAMINOURACIL METABOLITES OF CAFEINE IN HUMAN URINEBRANFMAN AR; MCCOMISH MF; BRUNI RJ et al.1983; DRUG METABOLISM AND DISPOSITION; ISSN 0090-9556; USA; DA. 1983; VOL. 11; NO 3; PP. 206-210; BIBL. 7 REF.Article

CHARACTERIZATION OF THE METABOLITES OF ELLIPTICINE IN RAT BILE.BRANFMAN AR; BRUNI RJ; REINHOLD VN et al.1978; DRUG METABOL. DISPOSIT.; USA; DA. 1978; VOL. 6; NO 5; PP. 542-548; BIBL. 12 REF.Article

COMPARISON OF THE METABOLISM IN DOGS OF ESTRADIOL-17BETA FOLLOWING ITS INTRAVENOUS AND ORAL ADMINISTRATIONLONGCOPE C; YESAIR DW; WILLIAMS KIH et al.1980; J. STEROID BIOCHEM.; ISSN 0022-4731; GBR; DA. 1980; VOL. 13; NO 9; PP. 1047-1055; BIBL. 23 REF.Article